Bengaluru, India

Shrutin Ulmann

This inventor holds 1 USPTO granted patent. Top assignee: Koninklijke Philips Corporation N.v.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shrutin Ulmann. Retrieved from https://idiyas.com/inventor/shrutin-ulmann-g3bkj4uu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Shrutin Ulmann

Introduction

Shrutin Ulmann is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of medical technology, particularly in cancer treatment. His innovative approach combines imaging technology with genetic analysis to enhance patient care.

Latest Patents

Ulmann holds a patent for a groundbreaking method titled "Mapping image signatures of cancer cells to genetic signatures." This patent describes a comprehensive system for treating patients with cancer. The method involves several steps, including receiving a sample from a patient, obtaining images of cancer cells, processing these images to extract coefficients, and mapping these coefficients to identify cancer cell types. Ultimately, this process aids in determining a specific course of treatment tailored to the identified cancer cell types.

Career Highlights

Shrutin Ulmann is currently employed at Koninklijke Philips Corporation N.V., where he continues to develop innovative solutions in healthcare technology. His work focuses on integrating advanced imaging techniques with genetic data to improve cancer diagnosis and treatment.

Collaborations

Ulmann collaborates with Prasad Raghotham Venkat, a fellow innovator in the field. Together, they work on advancing technologies that can significantly impact patient outcomes in oncology.

Conclusion

Shrutin Ulmann's contributions to cancer treatment through his innovative patent demonstrate the potential of combining imaging and genetic analysis. His work at Koninklijke Philips Corporation N.V. continues to pave the way for advancements in medical technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…